117 related articles for article (PubMed ID: 35180822)
1. Assessment of hepatic prostaglandin E
Oba KI; Shimada H; Hashimoto R; Kawase A; Nakanishi T; Iwaki M
Endocr Regul; 2022 Feb; 56(1):22-30. PubMed ID: 35180822
[No Abstract] [Full Text] [Related]
2. The regulatory mechanism involved in the prostaglandin E
Shimada H; Hashimoto R; Aoki A; Yamada S; Oba KI; Kawase A; Nakanishi T; Iwaki M
Prostaglandins Leukot Essent Fatty Acids; 2020 Apr; 155():102081. PubMed ID: 32155568
[TBL] [Abstract][Full Text] [Related]
3. Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury.
Higuchi S; Yano A; Takai S; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Toxicol Sci; 2012 Nov; 130(1):4-16. PubMed ID: 22790970
[TBL] [Abstract][Full Text] [Related]
4. Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats.
Iida A; Sasaki E; Yano A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Drug Metab Dispos; 2015 Jul; 43(7):958-68. PubMed ID: 25870103
[TBL] [Abstract][Full Text] [Related]
5. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
Yao L; Chen W; Song K; Han C; Gandhi CR; Lim K; Wu T
PLoS One; 2017; 12(4):e0176106. PubMed ID: 28423012
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice.
Wang Z; Xu G; Zhan X; Liu Y; Gao Y; Chen N; Guo Y; Li R; He T; Song X; Niu M; Wang J; Bai Z; Xiao X
Arch Toxicol; 2019 Dec; 93(12):3585-3599. PubMed ID: 31677073
[TBL] [Abstract][Full Text] [Related]
7. Pathogenetic analyses of carbamazepine-induced liver injury in F344 rats focused on immune- and inflammation-related factors.
Sasaki E; Iida A; Oda S; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Exp Toxicol Pathol; 2016 Jan; 68(1):27-38. PubMed ID: 26391595
[TBL] [Abstract][Full Text] [Related]
8. 15-Hydroxyprostaglandin dehydrogenase inhibitor prevents contrast-induced acute kidney injury.
Kim BW; Kim HJ; Kim SH; Baik HJ; Kang MS; Kim DH; Markowitz SD; Kang SW; Bae KB
Ren Fail; 2021 Dec; 43(1):168-179. PubMed ID: 33459127
[TBL] [Abstract][Full Text] [Related]
9. Hepatoprotective and antioxidant activity of N-acetyl cysteine in carbamazepine-administered rats.
Maheswari E; Saraswathy GR; Santhranii T
Indian J Pharmacol; 2014; 46(2):211-5. PubMed ID: 24741196
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rb1 Promotes Hepatic Glycogen Synthesis to Ameliorate T2DM Through 15-PGDH/PGE
Liang M; Zhan W; Wang L; Bei W; Wang W
Diabetes Metab Syndr Obes; 2023; 16():3223-3234. PubMed ID: 37867629
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat.
Panesar SK; Bandiera SM; Abbott FS
Drug Metab Dispos; 1996 Jun; 24(6):619-27. PubMed ID: 8781776
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice.
Nishizawa N; Ito Y; Eshima K; Ohkubo H; Kojo K; Inoue T; Raouf J; Jakobsson PJ; Uematsu S; Akira S; Narumiya S; Watanabe M; Majima M
J Hepatol; 2018 Jul; 69(1):110-120. PubMed ID: 29458169
[TBL] [Abstract][Full Text] [Related]
13. Acute hepatitis in a patient treated with carbamazepine.
Galeone D; Lamontanara G; Torelli D
J Neurol; 1985; 232(5):301-3. PubMed ID: 4056837
[TBL] [Abstract][Full Text] [Related]
14. Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries.
Sasaki E; Yokoi T
J Toxicol Sci; 2018; 43(2):75-87. PubMed ID: 29479037
[TBL] [Abstract][Full Text] [Related]
15. Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children.
Hadzagic-Catibusic F; Hasanbegovic E; Melunovic M; Zubcevic S; Uzicanin S
Med Arch; 2017 Aug; 71(4):239-242. PubMed ID: 28974841
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine promotes liver regeneration and survival in mice.
Kawaguchi T; Kodama T; Hikita H; Tanaka S; Shigekawa M; Nawa T; Shimizu S; Li W; Miyagi T; Hiramatsu N; Tatsumi T; Takehara T
J Hepatol; 2013 Dec; 59(6):1239-45. PubMed ID: 23872603
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 alterations during sepsis are partially mediated by endotoxin-induced inhibition of prostaglandin 15-hydroxydehydrogenase.
Hahn EL; Clancy KD; Tai HH; Ricken JD; He LK; Gamelli RL
J Trauma; 1998 May; 44(5):777-81; discussion 781-2. PubMed ID: 9603077
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of MK615 for the treatment of patients with liver disorders.
Hokari A; Ishikawa T; Tajiri H; Matsuda T; Ishii O; Matsumoto N; Okuse C; Takahashi H; Kurihara T; Kawahara K; Maruyama I; Zeniya M
World J Gastroenterol; 2012 Aug; 18(31):4118-26. PubMed ID: 22919243
[TBL] [Abstract][Full Text] [Related]
19. Effect of four-day treatment with carbamazepine at different dose levels on microsomal enzyme induction, drug metabolism and drug toxicity.
Regnaud L; Sirois G; Chakrabarti S
Pharmacol Toxicol; 1988 Jan; 62(1):3-6. PubMed ID: 3357875
[TBL] [Abstract][Full Text] [Related]
20. Altered plasma prostaglandin E
Rawat C; Shivangi ; Kushwaha S; Sharma S; Srivastava AK; Kukreti R
Prostaglandins Leukot Essent Fatty Acids; 2020 Feb; 153():102056. PubMed ID: 32007745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
